4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide,
AS 4370,
AS-4370,
mosapride,
mosapride citrate,
Mosapride UI05MSP015CT,
Mosapride citrate,
112885-42-4,
Gasmot,
AS-4370,
Mosapride (citrate),
Gasmotin,
TAK-370,
AS 4370,
4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide 2-hydroxypropane-1,2,3-tricarboxylate,
(+-)-4-Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide citrate,
DSSTox_CID_26207,
DSSTox_RID_81436,
DSSTox_GSID_46207,
Benzamide, 4-amino-5-chloro-2-ethoxy-N-((4-((4-fluorophenyl)methyl)-2-morpholinyl)methyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1),
4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]-benzamide 2-hydroxy-1,2,3-propanetricarboxylate,
CAS-112885-42-4,
citro; mosapride,
Mosapride-citrate,
C21H25ClFN3O3.C6H8O7,
AS-4370 citrate,
AC1L3P2N,
MLS006011997,
C27H33ClFN3O10,
SCHEMBL258620,
TAK370,
CHEMBL1733174,
DTXSID7046207,
CTK8F0731,
HY-B0189A,
KS-00000GOB,
TAK 370,
HMS2051P15,
HMS2234K07,
HMS3369K19,
HMS3393P15,
HMS3651O09,
TAK-370;AS-4370;Gasmotin,
Tox21_111874,
MFCD01666680,
Mosapride citrate - Adooq Bioscience,
s1385,
AKOS015895400,
Tox21_111874_1,
CCG-100966,
CS-2081,
MCULE-8781584252,
NC00216,
RL00527,
NCGC00160527-03,
AK481271,
AN-14995,
AS-13388,
CPD000469200,
I052,
LS-25428,
SAM001246713,
AB2000079,
RT-013942,
SW197596-2,
85M424,
I06-0660,
TAK-370, AS-4370, Gasmotin, 112885-42-4,
4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide citrate,
4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide; 2-hydroxypropane-1,2,3-tricarboxylic acid,
4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide; citric acid,
4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide;2-hydroxypropane-1,2,3-tricarboxylic acid.,
Benzamide, 4-amino-5-chloro-2-ethoxy-N-((4-((4-fluorophenyl)methyl)-2-morpholinyl)methyl)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1),
Mosapride,
TAK-370 citrate,
Mosapride citrate dihydrate,
UNII-MF497J489P,
Mosapride UI05MSP015CT,
MLS001401439,
MF497J489P,
ACN-S005337,
CID119583,
CS-O-01883,
NCGC00160527-01,
SMR000469200,
M-225,
C21-H25-Cl-F-N3-O3.C6-H8-O7,
C062720,
4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide,
156925-25-6,
4-Amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide citrate,
Benzamida, 4-amino-5-cloro-2-etoxi-n-[[4-[(4-fluorofenil)metil]-2-morfolinil]metil]-, 2-hidroxi-1,2,3-propanotricarboxilato (1:1),